Mechanistic Modeling is the next step in the drug pipeline

Mechanistic Modeling is the next step in the drug pipeline ...

This is part two of our three-part GENcast series, where we discuss various aspects of the drug discovery and development process, as well as how advanced computational techniques such as mechanistic modeling can help advance the therapeutic drug pipeline for many manufacturers. In this second GENcast, I sat down again with Dr. John Burke, the President, CEO, and co-founder of Applied BioMath, to discuss the specific applications of mechanistic modeling and how his company is helping biotech and pharmaceutical companies reduce their late-stage

GEN Podcasts The Quite Voice of Immunotherapy That Has Arrived

Panelist:

Biomath, a PhD co-founder, president, and CEO, is John M. Burke.

You may also like: